Jump to contents

Researcher Information

last modified:2022/05/30

Professor YONEDA Takashi

Mail Laboratory Website

Faculty, Affiliation

Faculty of Transdisciplinary Sciences, Institute of Philosophy in Interdisciplinary Sciences

College and School Educational Field

Division of Medical Sciences, Graduate School of Medical Science
Division of Medical Science, Graduate School of Medical Science

School of Medicine, College of Medical, Pharmaceutical and Health Sciences
Department of Laboratory Sciences,School of Health Sciences, College of Medical, Pharmaceutical and Health Sciences
School of Entrepreneurial and Innovation Studies, College of Transdisciplinary Sciences for Innovation

Laboratory

Department of Health Promotion and Medicine of the Future, Kanazawa University TEL:076-265-2778 FAX:076-234-4251

Academic Background

【Academic background(Doctoral/Master's Degree)】
Kanazawa University Doctor Graduate School, Division of Medicine 1994 Completed
【Academic background(Bachelor's Degree)】
Kanazawa University 199003

Career

Kanazawa University(1999/04/01-)

Year & Month of Birth

Academic Society









The Endocrine Society
Japan Diabetes Society




Award

Specialities

Endocrinology、Hypertension、Endocrinology、Metabolomics、Cardiovascular medicine、Medical sociology

Speciality Keywords

Endocrinology, Hypertension, Medical Innovation, Reguratory Science, Telemedicine,Health Promotion

Research Themes

Study on Pathogenesis of Endocrine tumor

Hypertension, Cardiovascular Endocrinology

Medical Innovation

Books

Papers

  •  Effect of cosyntropin during adrenal venous sampling on subtype of primary aldosteronism: analysis of surgical outcome. Kobayashi H, Nakamura Y, Abe M, Kurihara I, Itoh H, Ichijo T, Takeda Y, Yoneda T, Katabami T, Tsuiki M, Wada N, Ogawa Y, Sakamoto R, Kawashima J, Sone M, Inagaki N, Yoshimoto T, Yamada T, Okamoto R, Matsuda Y, Fujita M, Watanabe M, Tamura K, Tanabe A, Naruse M; JPAS/JRAS Study Group. Eur J Endocrinol.  182 3 265-273 2020/03
  •  Primary aldosteronism subtype discordance between computed tomography and adrenal venous sampling. Aono D, Kometani M, Karashima S, Usukura M, Gondo Y, Hashimoto A, Demura M, Furukawa K, Takeda Y, Kawashiri M, Yoneda T  Hypertens Res. 42 12 1942-1950 2019/12
  •  Genetic and epigenetic analyses of aldosterone-producing adenoma with hypercortisolemia. Kometani M, Yoneda T, Demura M, Aono D, Gondoh Y, Karashima S, Nishimoto K, Yasuda M, Horike SI, Takeda Y. Steroids.  151 108470 2019/11
  •  Effect of sodium glucose cotransporter 2 inhibitors on obstructive sleep apnea in patients with type 2 diabetes. Sawada K, Karashima S, Kometani M, Oka R, Takeda Y, Sawamura T, Fujimoto A, Demura M, Wakayama A, Usukura M, Yagi K, Takeda Y, Yoneda T. Endocr J.  2018/04
  •  Study Protocol for the Effects of Artificial Intelligence (AI)-Supported Automated Nutritional Intervention on Glycemic Control in Patients with Type 2 Diabetes Mellitus. Oka R, Nomura A, Yasugi A, Kometani M, Gondoh Y, Yoshimura K, Yoneda T. Diabetes Ther.  10 3 1151-1161 2019/06

show all

  •  The status of glycemic control and hypoglycemia in elderly patients visiting the outpatient department specializing in diabetes.  Soma Y, Oka R, Fujii S, Ito N, Kometani M, Karashima S, Takeda Y, Yoneda T, Asano A. Nihon Ronen Igakkai Zasshi.  2018/05
  •  Lateralizing Asymmetry of Adrenal Imaging and Adrenal Vein Sampling in Patients With Primary Aldosteronism. Wada N, Shibayama Y, Yoneda T, Naruse M その他15名 JPAS/JRAS Study Group. J Endocr Soc.  16 3 1393-1402 2019/05
  •  Insulin Secretion and Risk for Future Diabetes in Subjects with a Nonpositive Insulinogenic Index.  Aono D, Oka R, Kometani M, Takeda Y, Karashima S, Yoshimura K, Takeda Y, Yoneda T. J Diabetes Res. 2018/03
  •  High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A Large, Multicenter Cohort Study in Japan. Akehi Y, Yanase T,Yoneda T, Naruse M; その他37名 Japan Primary Aldosteronism Study Group. Diabetes Care 42 5 938-945 2019/05
  •  Impact of aldosterone-producing cell clusters on diagnostic discrepancies in primary aldosteronism. Kometani M, Yoneda T, Aono D, Karashima S, Demura M, Nishimoto K, Yamagishi M, Takeda Y. Oncotarget. 2018/05
  •  Impact of adrenocorticotropic hormone stimulation during adrenal venous sampling on outcomes of primary aldosteronism. Takeda Y, Umakoshi H, Takeda Y, Yoneda T, Naruse M; その他20名 JPAS Study Group. J Hypertens.  37 5 1077-1082 2019/05
  •  Correlation Between Lateralization Index of Adrenal Venous Sampling and Standardized Outcome in Primary Aldosteronism.  Umakoshi H, Tsuiki M, Yokomoto-Umakoshi M, Takeda Y, Takashi Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ashida K, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Yanase T, Hashimoto S, Yamada M, Yoshikawa Y, Kai T, Suzuki T, Kawamura T, Naruse M. J Endocr Soc. 2018/05
  •  C-Peptide Area Under the Curve at Glucagon Stimulation Test Predicts Glucose Improvements by GLP-1 Receptor Analogue: A Retrospective Observational Study. Ohbatake A, Yagi K, Karashima S, Shima Y, Miyamoto Y, Asaka H, Okazaki S, Kometani M, Kawashiri MA, Takeda Y, Yoneda T, Chujo D. Diabetes Ther.  10 2 673-681 2019/04
  •  Severe Mitral Regurgitation As a Result of Rupture of Mitral Valve Chordae Tendineae in a Patient With Graves Disease.  Karashima S, Tsuda T, Kometani M, Oka R, Demura M, Kawashiri MA, Takeda Y, Hayashi K, Yoneda T. J Endocr Soc. 2018/09
  •  Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function. Kobayashi H, Abe M, Yoneda T, Naruse M; その他22名 JPAS/JRAS Study Group. Hypertension.  74 3 630-638 2020/01
  •  Associations between Sleep-Disordered Breathing and Metabolic Risk Factors beyond Obesity. Wakabayashi Y, Oka R, Nakaya M, Karashima S, Kometani M, Sakurai M, Yoshimura K, Yoneda T. J Diabetes Res. 2018/10
  •  Madelung disease in a 58-year-old man.  Karashima S, Yoneda T. CMAJ.  2019/01
  •  The Occurrence of Apparent Bilateral Aldosterone Suppression in Adrenal Vein Sampling for Primary Aldosteronism.  Shibayama Y, Wada N, Naruse M, Kurihara I, Ito H, Yoneda T, Takeda Y, Umakoshi H, Tsuiki M, Ichijo T, Fukuda H, Katabami T, Yoshimoto T, Ogawa Y, Kawashima J, Ohno Y, Sone M, Fujita M, Takahashi K, Shibata H, Kamemura K, Fujii Y, Yamamoto K, Suzuki T. J Endocr Soc 2018/05
  •  Epigenetic Regulation of Aldosterone Synthase Gene by Sodium and Angiotensin II.  Takeda Y, Demura M, Wang F, Karashima S, Yoneda T, Kometani M, Hashimoto A, Aono D, Horike SI, Meguro-Horike M, Yamagishi M, Takeda Y. J Am Heart Assoc. 2018/05
  •  Insulin Secretion and Risk for Future Diabetes in Subjects with a Nonpositive Insulinogenic Index. Aono D, Oka R, Kometani M, Takeda Y, Karashima S, Yoshimura K, Takeda Y, Yoneda T. J Diabetes Res. 2018/05
  •  The Occurrence of Apparent Bilateral Aldosterone Suppression in Adrenal Vein Sampling for Primary Aldosteronism. Shibayama Y, Wada N, Naruse M, Kurihara I, Ito H, Yoneda T, Takeda Y, Umakoshi H, Tsuiki M, Ichijo T, Fukuda H, Katabami T, Yoshimoto T, Ogawa Y, Kawashima J, Ohno Y, Sone M, Fujita M, Takahashi K, Shibata H, Kamemura K, Fujii Y, Yamamoto K, Suzuki T.  J Endocr Soc.  2 5 398-407 2018/03
  •  Prevalence of primary aldosteronism without hypertension in the general population: Results in Shika study. Karashima S, Kometani M, Tsujiguchi H, Asakura H, Nakano S, Usukura M, Mori S, Ohe M, Sawamura T, Okuda R, Hara A, Takamura T, Yamagishi M, Nakamura H, Takeda Y, Yoneda T. Clin Exp Hypertens. 40 2 118-125 2018/03
  •  Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan. Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, Kurihara I, Itoh H, Umakoshi H, Tsuiki M, Ichijo T, Katabami T, Tanaka Y, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Yoneda T, Hashimoto S, Yanase T, Suzuki T, Kawamura T, Tabara Y, Matsuda F, Naruse M; Nagahama Study; JPAS Study Group. Hypertension 71 3 530-537 2018/03
  •  Renal glucosuria is not associated with atherosclerotic cardiovascular disease outcome in a general Japanese community.  Tada H, Kawashiri MA, Sakata K, Yoneda T, Yasuda K, Yamagishi M, Hayashi K. Atherosclerosis. 261 111-116. 2017/06
  •  Trajectories of Postload Plasma Glucose in the Development of Type 2 Diabetes in Japanese Adults. Oka R, Shibata K, Sakurai M, Kometani M, Yamagishi M, Yoshimura K, Yoneda T. J Diabetes Res. 5307523.  2017
  •  Cortisol overproduction results from DNA methylation of CYP11B1 in hypercortisolemia. Kometani M, Yoneda T, Demura M, Koide H, Nishimoto K, Mukai K, Gomez-Sanchez CE, Akagi T, Yokota T, Horike SI, Karashima S, Miyamori I, Yamagishi M, Takeda Y. Sci Rep.  7 1 11205 2017/09/11
  •  Ventricular Fibrillation Associated With Dynamic Changes in J-Point Elevation in a Patient With Silent Thyroiditis.  Karashima S, Tsuda T, Wakabayashi Y, Kometani M, Demura M, Ichise T, Kawashiri MA, Takeda Y, Hayashi K, Yoneda T. J Endocr Soc.  2 2 135-139. 2017/12/06
  •  Reply to Kawada: One-hour plasma glucose as a predictor of Type 2 diabetes mellitus.  Oka R, Aizawa T, Yoneda T, Yamagishi M. Diabet Med. 34 5 734. 2017
  •  Unilateral Primary Aldosteronism with Spontaneous Remission after Long-Term Spironolactone Therapy.  JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2012/02
  •  Protective effects of mineralocorticoid receptor blockade against neuropathy in experimental diabetic rats.  DIABETES OBESITY & METABOLISM 14 2 155-162 2012/02
  •  Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects.  HYPERTENSION RESEARCH 34 1 98-102 2011/01
  •  Effects of high sodium intake on cardiovascular aldosterone synthesis in stroke-prone spontaneously hypertensive rats. J Hypertens. 19 7 635-639 2001/03
  •  Multiple noncoding exons 1 of nuclear receptors NR4A family (nerve growth factor-induced clone B, Nur-related factor 1 and neuron-derived orphan receptor 1) and NR5A1 (steroidogenic factor 1) in human cardiovascular and adrenal tissues.  J Hypertens. 29 6 1185-95 2011/06
  •  Clinical characteristics of primary hyperaldosteronism due to adrenal microadenoma.  STEROIDS 76 12 1363-6 2011/11
  •  Cardiac aldosterone production in genetically hypertensive rats. Hypertension. 36 10 495-500 2000/10
  •  Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy. Circulation. 105 6 677-679 2002/02
  •  Two novel types of contiguous gene deletion of the AVPR2 and ARHGAP4 genes in unrelated Japanese kindreds with nephrogenic diabetes insipidus. HUMAN MUTATION 19 1 23-29 2002/01
  •  Genetic analysis of the cytochrome P-450c17alpha (CYP17) and aldosterone synthase (CYP11B2) in Japanese patients with 17alpha-hydroxylase deficiency. Clin Endocrinol 54 6 751-758 2001/06
  •  Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy. Endocrinology. 141 5 1901-1904 2000/05
  •  Brain nitric oxide synthase messenger RNA in central mineralocorticoid hypertension. Hypertension. 30 4 953-956 1997/10
  •  Nadir Aldosterone Levels After Confirmatory Tests Are Correlated With Left Ventricular Hypertrophy in Primary Aldosteronism.  Ohno Y, Sone M, Inagaki N, Kawashima A, Takeda Y, Yoneda T, Kurihara I, Itoh H, Tsuiki M, Ichijo T, Katabami T, Wada N, Sakamoto R, Ogawa Y, Yoshimoto T, Yamada T, Kawashima J, Matsuda Y, Kobayashi H, Kamemura K, Yamamoto K, Otsuki M, Okamura S, Izawa S, Okamoto R, Tamura K, Tanabe A, Naruse M; JPAS/JRAS Study Group.  Hypertension. 75 6 1475-1482.  2020/06

Conference Presentations

Others

Arts and Fieldwork

Patent

Theme to the desired joint research

○The role of cardiovacular hormone in the pathogenesis of hypertension

Grant-in-Aid for Scientific Research

○「末端肥大症の成因における遺伝子学的研究」(2001-) 
○「原発性アルドステロン症における網膜神経節細胞死―その機序と緑内障との比較―」(2021-2023) 
○「AIアプリPHRとVRを活用した3Dオンライン診療システムの構築」(2021-2023) 
○「生活習慣病における多機能携帯電話を用いた遠隔診療システムの構築」(2017-2019) 
○「地域医療における軽症糖尿病患者に対する在宅健康サービスの継続研究」(2013-2015)
○「地域医療における軽症糖尿病患者に対する在宅健康サービスの構築」(2010-2012) 

Competitive research funding,Contribution

Collaborative research,Consignment study

Classes (Bachelors)

○Entrepreneurship I(2021)
○Entrepreneur: Practical Strategy(2021)
○Introduction to Region-studies(2021)
○Introduction to Region-studies(2021)
○Innovation Essence Ⅱ(2021)
○Presentation and Debate(2021)
○Academic Skills(2021)
○Pathophysiology 2(2021)
○Innovation & Entrepreneurship II(2020)
○Pathophysiology 2(2020)
○Organ Physiology(2020)
○Introduction to Region-studies(2020)
○Practice of Wellness Promotion(2020)
○Practice of Wellness Promotion(2020)
○Practice of Wellness Promotion(2020)
○Practice of Wellness Promotion(2020)
○Health Promotion of the Future(2019)
○Practice of Wellness Promotion(2019)
○Practice of Wellness Promotion(2019)
○Health Promotion of the Future(2019)
○Presentation and Debate (Freshman Seminar II)(2019)
○Practice of Wellness Promotion(2019)
○Practice of Wellness Promotion(2019)
○Practice of Wellness Promotion(2019)
○Practice of Wellness Promotion(2019)
○Practice of Wellness Promotion(2019)
○Practice of Wellness Promotion(2019)
○Practice of Wellness Promotion(2019)
○Practice of Wellness Promotion(2019)
○Practice of Wellness Promotion(2019)
○Practice of Wellness Promotion(2019)
○Introduction to Information Technology(2019)
○Pathophysiology 2(2019)
○Medical innovation(2019)
○Introduction to Region-studies(2019)
○Health Promotion of the Future(2019)
○Practice of Wellness Promotion(2019)
○Practice of Wellness Promotion(2019)
○Freshman Seminar I(2019)

Classes (Graduate Schools)

○Health Promotion and Medicin of the Future(2021)
○Seminar of Medical Innovation(2021)
○Introduction to Health System in JapanⅡ(2021)
○Seminar of Medical Innovation(2021)
○Preventive Medicine(2021)
○Introduction to Health System in JapanⅠ(2021)
○Seminar on Regulatory Science(2021)
○Health Promotion and Medicin of the Future(2020)
○Health Promotion and Medicin of the Future(2020)
○Introduction to Health System in JapanⅠ(2020)
○Introduction to Health System in JapanⅡ(2020)
○Seminar of Medical Innovation(2020)
○Seminar on Regulatory Science(2020)
○Seminar of Medical Innovation(2020)
○Seminar of Medical Innovation(2020)
○Medical Sciences(2020)
○Seminar on Medical Innovation(2020)
○Seminar on Regulatory Science(2020)
○Preventive Medicine(2020)
○Seminar on Regulatory Science(2019)
○Seminar of Medical Innovation(2019)
○Seminar of Medical Innovation(2019)
○Introduction to Health System in JapanⅠ(2019)
○Introduction to Health System in JapanⅡ(2019)
○Seminar on Regulatory Science(2019)
○Seminar of Medical Innovation(2019)
○Health Promotion and Medicin of the Future(2019)
○Health Promotion and Medicin of the Future(2019)
○Preventive Medicine(2019)
○Seminar of Medical Innovation(2017)
○Seminar on Regulatory Science(2017)
○Seminar of Medical Innovation(2017)
○Seminar of Medical Innovation(2017)
○Seminar on Regulatory Science(2017)
○Seminar of Medical Innovation(2016)
○Seminar of Medical Innovation(2016)
○Seminar on Regulatory Science(2016)
○Seminar on Regulatory Science(2016)
○Seminar of Medical Innovation(2016)

International Project

International Students

Lecture themes

Others (Social Activities)

To Page Top